Celltrion’s Covid-19 antibody drug cut recovery time-early study – Times of India

South Korean drugmaker Celltrion Inc said on Friday patients treated with its experimental Covid-19 antibody drug in a small-size early-stage trial showed at least a [...]

The post Celltrion's Covid-19 antibody drug cut recovery time-early study - Times of India first appeared on Daily 2 Daily News.

from Daily 2 Daily News https://ift.tt/33gnRnq